These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25795336)
1. The role of contrast agents in the diagnosis of renal diseases. Nicolau C; Aldecoa I; Bunesch L; Mallofre C; Sebastia C Curr Probl Diagn Radiol; 2015; 44(4):346-59. PubMed ID: 25795336 [TBL] [Abstract][Full Text] [Related]
3. Imaging of focal liver lesions. Jang HJ; Yu H; Kim TK Semin Roentgenol; 2009 Oct; 44(4):266-82. PubMed ID: 19715792 [TBL] [Abstract][Full Text] [Related]
4. Focal renal lesions in pediatric patients. Son J; Lee EY; Restrepo R; Eisenberg RL AJR Am J Roentgenol; 2012 Dec; 199(6):W668-82. PubMed ID: 23169739 [No Abstract] [Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor. Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546 [TBL] [Abstract][Full Text] [Related]
11. Contemporary imaging of the renal mass. Kang SK; Chandarana H Urol Clin North Am; 2012 May; 39(2):161-70, vi. PubMed ID: 22487759 [TBL] [Abstract][Full Text] [Related]
12. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent. Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609 [TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced magnetic resonance imaging of the abdomen. Brown ED; Semelka RC Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the kidney. Renken NS; Krestin GP Semin Ultrasound CT MR; 2005 Jun; 26(3):153-61. PubMed ID: 15987064 [TBL] [Abstract][Full Text] [Related]
15. Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis? Thomsen HS; Marckmann P; Logager VB Acta Radiol; 2007 Jul; 48(6):593-6. PubMed ID: 17611863 [No Abstract] [Full Text] [Related]
16. Imaging of horseshoe kidneys and their complications. O'Brien J; Buckley O; Doody O; Ward E; Persaud T; Torreggiani W J Med Imaging Radiat Oncol; 2008 Jun; 52(3):216-26. PubMed ID: 18477115 [TBL] [Abstract][Full Text] [Related]
17. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Brasch RC; London DA; Wesbey GE; Tozer TN; Nitecki DE; Williams RD; Doemeny J; Tuck LD; Lallemand DP Radiology; 1983 Jun; 147(3):773-9. PubMed ID: 6844613 [TBL] [Abstract][Full Text] [Related]
19. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544 [TBL] [Abstract][Full Text] [Related]
20. Imaging techniques in the management of chronic kidney disease: current developments and future perspectives. Herget-Rosenthal S Semin Nephrol; 2011 May; 31(3):283-90. PubMed ID: 21784277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]